2016
DOI: 10.1016/j.intimp.2016.03.046
|View full text |Cite
|
Sign up to set email alerts
|

Expression patterns of sirtuin 1-AMPK-autophagy pathway in chronic colitis and inflammation-associated colon neoplasia in IL-10-deficient mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
25
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 43 publications
(29 citation statements)
references
References 44 publications
2
25
0
Order By: Relevance
“…In animal models, a paper by Kuhn et al [39] reported that IL-10-deficient mice developed chronic enterocolitis that can be prevented by administration of IL-10. Our group has also observed in this type of mice the spontaneous develop of chronic colitis and adenocarcinoma through a dysplasia sequence [40], and the reversal effects of experimental colitis by different treatments [41,42]. In the present study, the levels of IL-10 in the colon were found to be significantly increased in DSS mice and reduced in animals with higher doses, comparable to sham.…”
Section: Discussionsupporting
confidence: 72%
“…In animal models, a paper by Kuhn et al [39] reported that IL-10-deficient mice developed chronic enterocolitis that can be prevented by administration of IL-10. Our group has also observed in this type of mice the spontaneous develop of chronic colitis and adenocarcinoma through a dysplasia sequence [40], and the reversal effects of experimental colitis by different treatments [41,42]. In the present study, the levels of IL-10 in the colon were found to be significantly increased in DSS mice and reduced in animals with higher doses, comparable to sham.…”
Section: Discussionsupporting
confidence: 72%
“…3B and C), suggesting that AMPK-mTOR signaling pathway and tumor cell EMT may be inhibited. It has been reported that Sirt1 can activate the AMPK signaling pathway (23). To further confirm whether miR-138 directly regulate Sirt1 expression, the Dual-Luciferase reporter assay was conducted.…”
Section: Resultsmentioning
confidence: 99%
“…In T cells, TLR4-ligand LPS stimulated the TLR directing the cells toward type 1 polarization and expressed suppressor of cytokine signaling (SOCS) 1, and thus suppressed IL-10 expression (Ghosh et al, 2015). IL-10 was considered as a switch from tumor-promoting inflammation to antitumor immunity, and deficient IL-10 signaling developed tumors spontaneously and at high rates (Oft, 2014;Talero et al, 2016). LPS could activate TLR4 signaling in tumor cells and help tumor cells escape attack from cytotoxic lymphocyte (CTL) and natural killer (NK) cells (Huang et al, 2005).…”
Section: Discussionmentioning
confidence: 99%